Omnipaque™, the 2nd generation non-ionic X-ray product, is discovered (first registration 1982). Omnipaque became a so-called "blockbuster" pharmaceutical with end-user sales of over $1 billion a year and was for many years ranked among the top 10 pharmaceutical products sold world-wide. Even today, it is the top-selling X-ray contrast agent in the world.